Top 10 Companies in the Trypsin Market (2026): Market Leaders Powering Global Biopharma

MARKET INSIGHTS

Global trypsin market size was valued at USD 217 million in 2024 and is projected to grow from USD 237 million in 2025 to USD 384 million by 2034, exhibiting a CAGR of 8.7% during the forecast period.

Trypsin is a serine protease enzyme that plays a critical role in protein digestion and cell culture applications. Naturally found in the digestive systems of vertebrates, this enzyme specifically cleaves peptide bonds at the carboxyl side of lysine and arginine amino acids. While it occurs naturally in animals, commercial production primarily utilizes porcine and bovine sources due to their high yield and stability.

The market growth is driven by expanding applications in biopharmaceutical manufacturing and research laboratories, particularly for cell dissociation and protein digestion processes. North America and Asia Pacific dominate the market, collectively accounting for about 65% of global demand. Major players like Thermo Fisher, Corning, and Merck maintain strong market positions, with the top three producers controlling approximately 60% of total market share. Recent advancements in recombinant trypsin production are creating new opportunities, particularly for animal-free applications in sensitive bioprocessing workflows.

Trypsin Market – View in Detailed Research Report

Top 10 Companies in the Trypsin Market (2026)

🔟 1. Thermo Fisher Scientific Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: Cell culture trypsin, protein digestion enzymes, biopharma solutions

Thermo Fisher Scientific remains the market leader, offering a broad portfolio of high‑purity trypsin products for cell culture, vaccine manufacturing, and research applications. Their extensive distribution network across North America and Europe ensures rapid delivery to biopharma clients worldwide.

Sustainability & Growth Initiatives:

• Investing in recombinant trypsin development to reduce animal‑derived usage
• Expanding production capacity in Asia‑Pacific to meet growing demand
• Implementing advanced quality control to maintain batch consistency

---

9️⃣ 2. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Biopharma enzymes, cell culture reagents, diagnostics

Merck KGaA supplies high‑purity trypsin for biopharmaceutical production and research labs, supporting cell dissociation and protein processing workflows. The company focuses on integrating sustainable manufacturing practices across its global facilities.

Sustainability & Growth Initiatives:

• Developing plant‑based trypsin alternatives to meet regulatory demands
• Enhancing supply chain resilience through regional production hubs
• Collaborating with contract manufacturing organizations in Asia

---

8️⃣ 3. Corning Incorporated

Headquarters: Corning, New York, USA
Key Offering: Cell culture substrates, trypsin solutions, bioprocessing equipment

Corning’s expertise in cell culture technologies positions it as a key supplier of trypsin for vaccine and biologics manufacturing. The company emphasizes product reliability and consistency across its global distribution network.

Sustainability & Growth Initiatives:

• Investing in next‑generation trypsin formulations with reduced batch variability
• Expanding partnerships with academic research institutions
• Leveraging digital tools for real‑time quality monitoring

---

7️⃣ 4. Cytiva

Headquarters: Marlborough, Massachusetts, USA
Key Offering: Advanced trypsin formulations, bioprocessing solutions, downstream technologies

Cytiva focuses on delivering high‑performance trypsin products that meet stringent GMP requirements for biopharmaceutical manufacturing. The company’s research initiatives target improved enzyme stability and shelf life.

Sustainability & Growth Initiatives:

• Developing lyophilized trypsin with >90% activity after 24 months at room temperature
• Implementing continuous manufacturing processes to reduce waste
• Expanding presence in emerging markets such as Brazil and India

---

6️⃣ 5. Bioseutica

Headquarters: Delft, Netherlands
Key Offering: Recombinant trypsin, enzyme purification technologies, bioprocess solutions

Bioseutica specializes in recombinant trypsin production, providing animal‑free alternatives for cell culture and vaccine manufacturing. Their scalable microbial expression platforms enable high‑yield, high‑purity enzyme production.

Sustainability & Growth Initiatives:

• Enhancing recombinant expression systems for higher yields
• Partnering with contract manufacturing organizations in Asia‑Pacific
• Investing in process automation to reduce production costs

---

5️⃣ 6. Lonza Group AG

Headquarters: Basel, Switzerland
Key Offering: Cell culture enzymes, bioprocessing solutions, recombinant proteins

Lonza’s extensive enzyme portfolio includes high‑purity trypsin for biopharmaceutical and research applications. The company focuses on expanding its manufacturing footprint in Asia‑Pacific to support regional biopharma growth.

Sustainability & Growth Initiatives:

• Developing plant‑based trypsin variants to meet regulatory demands
• Implementing green chemistry practices in enzyme production
• Strengthening collaborations with academic institutions

---

4️⃣ 7. Sartorius AG

Headquarters: Göttingen, Germany
Key Offering: Bioprocess equipment, enzyme solutions, downstream technologies

Sartorius provides high‑performance trypsin solutions tailored for large‑scale biopharma manufacturing. The company invests heavily in M&A to strengthen its Asia‑Pacific presence.

Sustainability & Growth Initiatives:

• Expanding M&A portfolio to include leading enzyme manufacturers
• Investing in continuous manufacturing platforms for enzyme production
• Implementing digital quality management systems

---

3️⃣ 8. BBI Group

Headquarters: London, United Kingdom
Key Offering: Enzyme solutions, bioprocessing equipment, diagnostics

BBI Group supplies a range of trypsin products for biopharma and research applications. The company focuses on product innovation and quality assurance to support complex bioprocesses.

Sustainability & Growth Initiatives:

• Developing recombinant trypsin to reduce animal‑derived usage
• Investing in process optimization to lower environmental footprint
• Expanding distribution in emerging markets

---

2️⃣ 9. Geyuantianrun Bio-tech

Headquarters: Shanghai, China
Key Offering: Cell culture enzymes, biopharma solutions, recombinant proteins

Geyuantianrun Bio-tech serves the rapidly growing Chinese biopharma market with high‑purity trypsin products. The company emphasizes local manufacturing capabilities to meet domestic demand.

Sustainability & Growth Initiatives:

• Expanding recombinant enzyme production capacity
• Implementing stringent quality control protocols
• Partnering with regional contract manufacturers

---

1️⃣ 10. Linzyme Biosciences

Headquarters: Hyderabad, India
Key Offering: Enzyme solutions, bioprocessing reagents, research tools

Linzyme Biosciences supplies trypsin for research and biopharma applications across India and the Asia‑Pacific region. The company focuses on scalable production and cost‑effective solutions.

Sustainability & Growth Initiatives:

• Developing recombinant trypsin to meet regulatory demands
• Investing in green manufacturing practices
• Expanding product line to include ready‑to‑use solutions

---

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/297722/trypsin-forecast-market

---

Get Full Report: https://www.24chemicalresearch.com/reports/297722/trypsin-forecast-market

Outlook

The trypsin market is set to continue its robust expansion, driven by the growing biopharmaceutical sector and the increasing adoption of cell‑based vaccine platforms. With a projected CAGR of 8.7%, the market is expected to reach USD 384 million by 2034. The shift towards animal‑free recombinant trypsin and the expansion of manufacturing capabilities in Asia‑Pacific are key factors that will sustain this growth trajectory.

Future Trends

• Accelerated development of recombinant and plant‑based trypsin to address safety and regulatory concerns.
• Growing demand for lyophilized and ready‑to‑use trypsin formulations that enhance shelf life and ease of use.
• Adoption of continuous bioprocessing technologies to improve yield and reduce production time.
• Strategic mergers and acquisitions to consolidate market leadership and expand geographic reach.
• Increased focus on sustainability, including green chemistry and waste reduction in enzyme production.